CAS Registry Number is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-07-26. Numbers and descriptions here follow the published literature rather than marketing material.
In laboratory settings, dihexa is typically handled as a research chemical rather than a pharmaceutical product. Suppliers may provide it as a lyophilized powder or in solution, and purity is often stated as a percentage determined by chromatographic analysis. Because independent verification is uncommon, researchers generally rely on certificates of analysis, which may include high-performance liquid chromatography and mass spectrometry data. The absence of pharmacopeial monographs means that identity, purity, and impurity profiles can vary between batches and suppliers.
Storage recommendations for peptides and peptide-like compounds usually emphasize low temperatures, desiccation, and protection from light. A common practice is to keep dry powder at -20 °C or below and to prepare solutions shortly before use. Repeated freeze-thaw cycles may degrade the material, so aliquoting is often advised. Solubility depends on the solvent; aqueous solubility may be limited, and organic solvents such as dimethyl sulfoxide are sometimes used for stock solutions. Stability data specific to dihexa are sparse, so general peptide handling guidelines are often applied instead.
Analytical confirmation generally combines a separation method with a detection method. Reverse-phase high-performance liquid chromatography can assess purity, while mass spectrometry supports molecular identity. For research-grade material, a certificate of analysis may report a batch-specific purity value, but it does not guarantee biological activity or safety. Regulatory frameworks vary by country; many jurisdictions treat dihexa as a research chemical not intended for human consumption. Purchasers should verify local rules and supplier documentation. The absence of official standards makes independent testing and careful record-keeping important for laboratory work.
The compound originated from work on angiotensin IV, a peptide fragment of the renin-angiotensin system. Researchers modified angiotensin IV-related structures to produce molecules with altered stability and activity. Dihexa emerged from that effort and was reported to promote dendritic spine growth in cultured neurons. Some studies link its effects to hepatocyte growth factor signaling and the c-Met receptor, while other work points to insulin-regulated aminopeptidase. The precise primary target remains a subject of investigation, and findings may depend on cell type, assay conditions, and species.
In animal research, dihexa has been administered through several routes, and reports describe improved performance on spatial learning and memory tasks in rodents. These results are frequently cited in discussions of nootropic compounds. However, species differences, small sample sizes, and varied testing protocols limit how far the findings can be generalized. No large randomized controlled trials in humans have established efficacy or long-term safety. Claims about human cognitive enhancement therefore remain speculative, and the compound is best described as an experimental laboratory substance rather than a proven therapeutic or supplement.
Dihexa is a synthetic compound studied in laboratory and animal models for effects on synaptic connectivity and cognitive performance. It is often described as a peptide analog because its structure incorporates amino acid residues linked to a hexanoic acid group. The molecule is not a naturally occurring human hormone or neurotransmitter. Its name appears in research literature and online discussions, but it has not been approved as a medicine by major regulatory agencies. Most information comes from preclinical experiments rather than controlled human trials.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typical for lyophilized peptide-like research chemicals. |
| Solubility | Limited in water; soluble in some organic solvents | DMSO is commonly used for stock solutions. |
| Typical storage | -20 °C or below, desiccated, protected from light | Avoid repeated freeze-thaw cycles. |
| Purity assessment | Reverse-phase HPLC with UV detection | Mass spectrometry is often used for identity confirmation. |
| Common document | Certificate of analysis | Batch-specific; does not establish safety or efficacy. |
Most published work on dihexa consists of preclinical studies using cell cultures or rodents. Reports have described effects on synaptic connectivity and performance on cognitive tasks in some animal models. These findings are generally presented as preliminary and require independent replication. Study designs, doses, and outcome measures vary across experiments, which complicates direct comparison. No large controlled human trials have established efficacy or safety for any medical use. At present, the evidence base is limited.
Regulatory agencies have not approved dihexa as a prescription drug or supplement. In many countries it falls into a gray area when sold for laboratory research. Buyers may encounter products marketed for research use only, which are not intended for human consumption. Purity and identity can vary between suppliers and batches. Certificates of analysis and independent testing are often recommended for research materials. Documentation helps verify what a vial contains.
Discussion of dihexa in online communities sometimes outpaces the scientific record. Anecdotal reports are difficult to verify and may not distinguish effects from placebo or expectation. The absence of approved human data means long-term risks remain unknown. Researchers continue to investigate related compounds and pathways. Open questions include whether animal findings translate to humans and which biological targets matter most. No consensus exists on these points. Current reviews emphasize the need for rigorous clinical research.
The full name often given is N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. This name indicates a chain containing tyrosine, isoleucine, and a six-carbon amino acid derivative. Databases list a CAS Registry Number and a molecular formula for the compound. The peptide is small compared with proteins, and its structure allows it to be studied in cell cultures and animal models. Exact identity depends on the supplier's synthesis and purification process. Minor impurities can remain after synthesis.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
Dihexa is a synthetic peptide that has been examined in laboratory and animal research. Its design is based on angiotensin IV, a naturally occurring peptide fragment produced in the body. The short name dihexa appears in scientific papers and online discussions, while the full chemical name describes a modified peptide chain. It is not a vitamin, mineral, or plant-derived compound. Suppliers typically present it as a research chemical rather than an approved medicine.
== Fourier transform mass spectrometry == Fourier transform ion cyclotron resonance mass spectrometry was developed by Alan G. Marshall and Melvin B. Comisarow at the University of British Columbia in 1974. The inspiration was earlier developments in conventional ICR and Fourier Transform Nuclear Magnetic Resonance (FT-NMR) spectroscopy.
== Origin == The existence of natriuretic peptides was predicted over fifty years ago by key cell biological observations. Atrial cells were found to contain highly developed Golgi networks and spherical granules, while balloon distension of the atria correlated with increased urination in dogs. De Bold and colleagues linked these studies and discovered the first natriuretic peptide that works by stimulating renal sodium and water secretion. Shortly after, atrial peptides with natriuretic, diuretic, and/or smooth muscle relaxing activity were purified and sequenced. The 1980s saw an increase in natriuretic peptide research, particularly due to the 1981 work by de Bold et al., which found that giving rats an extract of rat atrial tissue quickly reduced blood pressure and increased urination. To pinpoint the molecule causing this action, various structures that would eventually come to be known as an atrial natriuretic peptide, or ANP, were discovered. Kangawa and Matsuo determined the complete amino acid sequence of α-hANP using protein isolated from human atrial tissue. They were able to isolate and identify BNP and CNP from porcine brain in 1988 and 1990, respectively. The first of these hormones is most frequently referred to as atrial natriuretic peptide (ANP), whereas the second hormone, B-type natriuretic peptide (BNP), was formerly known as brain natriuretic peptide but is now more frequently linked to the cardiac ventricles of people with heart failure.
The increase in violence related with organized crime has significantly deteriorated the conditions in which local journalism is practiced. In the first years of the 21st century, Mexico was considered the most dangerous country to practice journalism, according to groups like the National Human Rights Commission, Reporters Without Borders, and the Committee to Protect Journalists. Between 2000 and 2012, several dozen journalists, including Miguel Ángel López Velasco, Luis Carlos Santiago, and Valentín Valdés Espinosa, were murdered there for covering the Mexican drug war. The offices of Televisa and local newspapers have been bombed. Cartels have also threatened to kill news reporters in the U.S. who have done coverage on the drug violence. Some media networks stopped reporting on drug crimes, while others have been infiltrated by cartels. Since harassment neutralized many traditional media outlets, anonymous, sensationalized blogs like Blog del Narco took on the role of reporting on events related to the drug war. Cartels responded by targeting bloggers and citizen journalists active on social media. Several have been tortured or killed for posting and denouncing cartel activities. In September 2011, citizen journalist NenaDLaredo of the website Nuevo Laredo Envivo was allegedly murdered by Los Zetas. In May 2012, several journalist murders occurred in Veracruz. Regina Martinez of Proceso was murdered in Xalapa. A few days later, three Veracruz photojournalists were tortured and killed, and their dismembered bodies were dumped in a canal.
A Kingdon trap consists of a thin central wire, an outer cylindrical electrode and isolated end cap electrodes at both ends. A static applied voltage results in a radial logarithmic potential between the electrodes. In a Kingdon trap there is no potential minimum to store the ions; however, they are stored with a finite angular momentum about the central wire and the applied electric field in the device allows for the stability of the ion trajectories. In 1981, Knight introduced a modified outer electrode that included an axial quadrupole term that confines the ions on the trap axis. The dynamic Kingdon trap has an additional AC voltage that uses strong defocusing to permanently store charged particles. The dynamic Kingdon trap does not require the trapped ions to have angular momentum with respect to the filament. An Orbitrap is a modified Kingdon trap that is used for mass spectrometry. Though the idea has been suggested and computer simulations performed neither the Kingdon nor the Knight configurations were reported to produce mass spectra, as the simulations indicated mass resolving power would be problematic.
Sources: en.wikipedia.org
== Education and background == Thomsen went to boarding school in Epsom, Surrey in Great Britain from 1967 to 1971. He graduated from high school from Rungsted Statsskole in 1979. He holds a master's degree from The Royal Veterinary and Agricultural University in 1986, now part of the University of Copenhagen. According to Krogsgaard Thomsen himself, he originally wanted to be a practicing veterinarian, and was inspired by the British television series All Creatures Great And Small. At the Royal Veterinary and Agricultural University, however, he started to take an interest in pursuing a career in either science or the pharmaceutical industry. He finished his PhD. from the same university in 1989 and obtained the DSc. (Doctor of Science) degree within the pharmacology of experimental therapeutics in 1991.
== History == The coupling of chromatography with MS is a well developed chemical analysis strategy dating back from the 1950s. Gas chromatography (GC)–MS was originally introduced in 1952, when A. T. James and A. J. P. Martin were trying to develop tandem separation – mass analysis techniques. In GC, the analytes are eluted from the separation column as a gas and the connection with electron ionization (EI) or chemical ionization (CI) ion sources in the MS system was a technically simpler challenge. Because of this, the development of GC-MS systems was faster than LC–MS and such systems were first commercialized in the 1970s. The development of LC–MS systems took longer than GC-MS and was directly related to the development of proper interfaces. Victor Talrose and his collaborators in Russia started the development of LC–MS in the late 1960s, when they first used capillaries to connect an LC column to an EI source. A similar strategy was investigated by McLafferty and collaborators in 1973 who coupled the LC column to a CI source, which allowed a higher liquid flow into the source. This was the first and most obvious way of coupling LC with MS, and was known as the capillary inlet interface. This pioneer interface for LC–MS had the same analysis capabilities of GC-MS and was limited to rather volatile analytes and non-polar compounds with low molecular mass (below 400 Da). In the capillary inlet interface, the evaporation of the mobile phase inside the capillary was one of the main issues.
was arrested in Dubai on 18 June 2020, due to an international arrest warrant that was sent out by the Belgian courts for his involvement in large scale drug trafficking, but he was eventually released on bail. The majority of the Turtle clan members are currently suspected of hiding out in Dubai and Nador, Morocco. In 2016, a member of the family celebrated his wedding in the Borgerhout district of Antwerp, causing controversy throughout the country as well as on social media. The controversy revolved particularly around the procession that included dozens of luxury cars, which paraded through the lower class district of Borgerhout. According to the Belgian press, the price of these cars was estimated at €7 million. Since 2018, many grenade attacks have occurred in the streets of Antwerp. They are particularly linked to the organisation of the Turtles.
Sources: en.wikipedia.org
Dry powder is usually kept frozen, desiccated, and protected from light. Solutions are often aliquoted to avoid repeated freeze-thaw cycles. Specific stability data for dihexa are limited, so general peptide storage practices are commonly used.
Reverse-phase HPLC is commonly used to estimate purity, and mass spectrometry helps confirm molecular identity. Certificates of analysis may summarize these results. Independent testing can provide additional verification when standards are unavailable.
In many countries, dihexa is not approved as a medicine and is sold only for research purposes. Regulations differ by jurisdiction, and import or possession rules may apply. Buyers should confirm local legal status before obtaining it.
Dihexa is a synthetic peptide-like compound studied primarily in preclinical models. It is often classified as an angiotensin IV analog and has been investigated for effects on neuronal connectivity. It is not an approved drug or dietary supplement.